down arrow

Marksans Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE750C01026
  • NSEID: MARKSANS
  • BSEID: 524404
INR
204.05
9.55 (4.91%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 14.67 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Net Sales
681.85
641.92
590.62
560.01
586.13
531.24
500.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
681.85
641.92
590.62
560.01
586.13
531.24
500.03
Raw Material Cost
189.26
214.39
161.31
148.38
192.87
174.70
151.76
Purchase of Finished goods
111.95
134.32
167.24
162.98
81.31
85.29
114.71
(Increase) / Decrease In Stocks
-2.87
-90.31
-66.76
-41.53
-1.36
-7.27
-23.71
Employee Cost
88.44
84.16
80.48
79.75
74.53
71.13
68.24
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
-0.01
-0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
156.30
163.68
119.93
100.80
105.76
93.44
87.07
Total Expenditure (Excl Depreciation)
543.08
506.24
462.19
450.37
453.11
417.29
398.07
Operating Profit (PBDIT) excl Other Income
138.77
135.68
128.43
109.64
133.02
113.95
101.96
Other Income
27.85
11.06
14.95
16.53
4.80
19.00
10.10
Operating Profit (PBDIT)
166.62
146.74
143.38
126.17
137.82
132.95
112.06
Interest
2.67
2.63
2.92
4.84
3.16
1.63
1.58
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
163.95
144.11
140.46
121.33
134.66
131.32
110.48
Depreciation
20.69
19.51
20.44
21.06
22.00
17.55
13.66
Profit Before Tax
143.26
124.60
120.02
100.28
112.66
113.77
96.83
Tax
38.19
26.84
30.95
22.63
29.69
29.92
26.39
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
105.07
97.76
89.07
77.64
82.97
83.85
70.44
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
105.07
97.76
89.07
77.64
82.97
83.85
70.44
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.50
1.04
0.32
-0.65
-0.27
0.33
1.78
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
104.56
96.72
88.75
78.29
83.24
83.52
68.66
Equity Capital
45.32
45.32
45.32
45.32
45.32
45.32
45.32
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
2,236.08
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
2.31
2.13
1.96
1.73
1.84
1.84
1.52
Diluted Earnings per share
2.31
2.13
1.96
1.73
1.84
1.84
1.52
Operating Profit Margin (Excl OI)
20.35%
21.14%
21.74%
19.58%
22.69%
21.45%
20.39%
Gross Profit Margin
24.04%
22.45%
23.78%
21.67%
22.97%
24.72%
22.09%
PAT Margin
15.41%
15.23%
15.08%
13.86%
14.16%
15.78%
14.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2024 is 6.22% vs 8.69% in Sep 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2024 is 8.11% vs 8.98% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2024 is 2.28% vs 5.65% in Sep 2024

stock-summary

Interest

QoQ Growth in quarter ended Dec 2024 is 1.52% vs -9.93% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

Compare Quarterly Results Of Marksans Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
681.85
3,230.00
-2,548.15
-78.89%
Other Operating Income
0.00
0.00
0.00
Total Operating income
681.85
3,230.00
-2,548.15
-78.89%
Raw Material Cost
189.26
536.11
-346.85
-64.70%
Purchase of Finished goods
111.95
387.30
-275.35
-71.09%
(Increase) / Decrease In Stocks
-2.87
11.81
-14.68
-124.30%
Employee Cost
88.44
709.71
-621.27
-87.54%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
156.30
755.27
-598.97
-79.31%
Total Expenditure (Excl Depreciation)
543.08
2,400.20
-1,857.12
-77.37%
Operating Profit (PBDIT) excl Other Income
138.77
829.80
-691.03
-83.28%
Other Income
27.85
77.32
-49.47
-63.98%
Operating Profit (PBDIT)
166.62
907.12
-740.50
-81.63%
Interest
2.67
220.93
-218.26
-98.79%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
163.95
686.19
-522.24
-76.11%
Depreciation
20.69
192.30
-171.61
-89.24%
Profit Before Tax
143.26
497.33
-354.07
-71.19%
Tax
38.19
112.81
-74.62
-66.15%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
105.07
381.08
-276.01
-72.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
105.07
381.08
-276.01
-72.43%
Share in Profit of Associates
0.00
3.44
-3.44
-100.00%
Minority Interest
0.50
4.29
-3.79
-88.34%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
104.56
380.23
-275.67
-72.50%
Equity Capital
45.32
40.06
5.26
13.13%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
2.31
9.49
-7.18
-75.66%
Diluted Earnings per share
2.31
9.44
-7.13
-75.53%
Operating Profit Margin (Excl OI)
20.35%
25.69%
0.00
-5.34%
Gross Profit Margin
24.04%
21.24%
0.00
2.80%
PAT Margin
15.41%
11.90%
0.00
3.51%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 681.85 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 6.22% vs 8.69% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 16.33% vs 22.15% in Dec 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit 104.56 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 8.11% vs 8.98% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 25.61% vs 31.27% in Dec 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 138.77 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 2.28% vs 5.65% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 4.32% vs 73.56% in Dec 2023

Quarterly - Interest
Interest 2.67 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 1.52% vs -9.93% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -15.51% vs 34.47% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.35%
in Dec 2024

Figures in Rs %
stock-summary

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023